Literature DB >> 35308477

Epidemiological and Genetic Aspects of NAFLD and NASH in Mexico.

Paulina Vidal-Cevallos1, Aldo Torre2, Nahum Mendez-Sanchez3, Misael Uribe1, Norberto C Chavez-Tapia1.   

Abstract

Content available: Author Interview and Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35308477      PMCID： PMC8912226          DOI： 10.1002/cld.1167

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  25 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care.

Authors:  Llorenç Caballeria; Salvador Augustin; Teresa Broquetas; Rosa Maria Morillas; Mercè Vergara; Silvia Virolés; Mª Rosario Hernández; Isabel Serra; Alberto Goday; Lluis Vila; Antonio Siso-Almirall; Rosa Solans; Jose Manuel Fernández-Real; Jose Antonio Carrión; Isabel Graupera; Pere Ginès
Journal:  Med Clin (Barc)       Date:  2019-06-06       Impact factor: 1.725

3.  Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Rolf Hultcrantz; Stergios Kechagias
Journal:  J Hepatol       Date:  2017-08-10       Impact factor: 25.083

4.  Prevalence of Metabolic Syndrome in Mexico: A Systematic Review and Meta-Analysis.

Authors:  Ana Ligia Gutiérrez-Solis; Sudip Datta Banik; Rosa María Méndez-González
Journal:  Metab Syndr Relat Disord       Date:  2018-07-31       Impact factor: 1.894

5.  The management of incidental fatty liver found on imaging. What do we need to do?

Authors:  Nahum Méndez-Sánchez; Norberto C Chavez-Tapia; Paloma Almeda-Valdes; Misael Uribe
Journal:  Am J Gastroenterol       Date:  2018-03-16       Impact factor: 10.864

Review 6.  The prevalence of nonalcoholic fatty liver disease in the Americas.

Authors:  Jorge A López-Velázquez; Karen V Silva-Vidal; Guadalupe Ponciano-Rodríguez; Norberto C Chávez-Tapia; Marco Arrese; Misael Uribe; Nahum Méndez-Sánchez
Journal:  Ann Hepatol       Date:  2014 Mar-Apr       Impact factor: 2.400

7.  A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.

Authors:  Federico Piñero; Paulo Costa; Yuri Longatto Boteon; Sergio Hoyos Duque; Sebastian Marciano; Margarita Anders; Adriana Varón; Alina Zerega; Jaime Poniachik; Alejandro Soza; Martín Padilla Machaca; Josemaría Menéndez; Rodrigo Zapata; Mario Vilatoba; Linda Muñoz; Martín Maraschio; Luis G Podestá; Lucas McCormack; Adrian Gadano; Ilka S F Fatima Boin; Parente García; Marcelo Silva
Journal:  Clin Res Hepatol Gastroenterol       Date:  2018-10       Impact factor: 2.947

Review 8.  Obesity in Mexico: rapid epidemiological transition and food industry interference in health policies.

Authors:  Simón Barquera; Juan A Rivera
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08-18       Impact factor: 32.069

9.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

Review 10.  The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider.

Authors:  Nicolás Salva-Pastor; Norberto C Chávez-Tapia; Misael Uribe; Natalia Nuño-Lámbarri
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.